DNA X, Inc.
Income Statement
| Line Item | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $27.6M | $26.8M | $25.8M | $24.1M | $20.5M | $12.0M | $13.3M | $15.9M |
| Cost of Revenue | $22.0M | $22.4M | $21.6M | $20.2M | $17.2M | $9.1M | $11.7M | $16.4M |
| Gross Profit | $5.6M | $4.4M | $4.2M | $3.9M | $3.3M | $2.8M | $1.5M | $-487.0K |
| Gross Margin | 20.3% | 16.5% | 16.2% | 16.3% | 16.2% | 23.8% | 11.5% | -3.1% |
| Operating Expenses | ||||||||
| Research & Development | $741.0K | — | $105.0K | $1.2M | $-135.0K | $2.7M | $4.2M | $3.9M |
| SG&A Expense | $2.0M | $1.9M | $2.0M | $2.3M | $3.9M | $2.3M | $2.3M | $2.7M |
| Operating Income | $688.0K | $747.0K | $333.0K | $-1.1M | $-1.9M | $-4.2M | $-7.1M | $-11.7M |
| Operating Margin | 2.5% | 2.8% | 1.3% | -4.4% | -9.4% | -35.3% | -53.4% | -73.7% |
| Interest Expense | — | — | $0 | — | — | — | $39.0K | — |
| Pretax Income | $623.0K | $581.0K | $340.0K | $-1.1M | $-1.5M | $-4.2M | $-7.1M | $-11.8M |
| Income Tax Expense | $96.0K | $72.0K | $113.0K | $-17.0K | $72.0K | $61.0K | $68.0K | $-60.0K |
| Net Income | $527.0K | $509.0K | $227.0K | $-1.0M | $-1.6M | $-4.2M | $-7.2M | $-11.7M |
| Net Margin | 1.9% | 1.9% | 0.9% | -4.3% | -7.8% | -35.3% | -54.4% | -73.6% |
| EPS (Basic) | $0.04 | $0.04 | $0.00 | $0.05 | $0.00 | $-0.02 | $-0.04 | $-0.04 |
| EPS (Diluted) | $0.04 | $0.04 | $0.00 | $0.05 | $0.00 | $-0.02 | $-0.04 | $-0.14 |
| Shares Outstanding (Basic) | 12.9M | 12.7M | 122.7M | 86.7M | 324.8M | 173.6M | 172.0M | 85.2M |
| Shares Outstanding (Diluted) | 13.3M | 13.4M | 123.3M | 86.7M | 324.8M | 173.6M | 172.0M | 85.2M |
| Dividends Per Share | — | — | — | — | — | — | — | — |